Guideline Central Blog

AAN

Guidelines Spotlight - Epilepsy in Women

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication – Guidelines Spotlight

Posted on

A focused guideline update “Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication” was released by the American Academy of Neurology (AAN), the American Epilepsy Society (AES), and the Society for Maternal-Fetal Medicine (SMFM) on May 15, 2024. The new guideline updates the previous 2009 guideline for “Management Issues for Women with […]

Posted in Guidelines, Miscellaneous, News, Uncategorized | Tagged , , , , ,
What's Changed - Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS) Guidelines – What’s Changed

Posted on

Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease, is a neurological disorder that impacts the motor neurons responsible for controlling voluntary muscle movement and breathing, according to the National Institutes of Health (NIH). The Centers for Disease Control and Prevention (CDC) has reported that at least 16,000 Americans are affected by ALS. […]

Posted in Alerts, Miscellaneous, News | Tagged , , ,
« Back to Blog
Categories
Tags

2022 Recap Abstracts ACC/AHA AGA AHRQ American Gastroenterological Association Aortic Disease Approved Drugs Breast Cancer Breast Cancer Awareness Month Cardiology Guidelines Clinical Guidelines Clinical Practice Guidelines Clinical Trials Colorectal Cancer Colorectal Cancer Awareness Month Colorectal Cancer Screening Guidelines Diabetes FDA & Drugs FDA Approvals FDA Approved Guideline Adherence Guideline Alerts Guideline Implementation Strategy Guidelines Guidelines Library Guideline Summaries Healthcare IBS Guidelines International Guidelines Irritable Bowel Syndrome (IBS) Lung Cancer Medical Conference medical journals Medications Monographs Monthly Alerts New April Guidelines News NGC Publications PubMed Research Tuberculosis Guidelines USPSTF